Coryneine is primarily studied for its potential neuroprotective and cognitive-enhancing properties. It has shown activity in modulating neurotransmitter systems in the brain, particularly those involving acetylcholine, which plays a key role in memory and learning processes. Due to this action, it is investigated for its possible use in the treatment of neurodegenerative disorders such as Alzheimer's disease. Additionally, coryneine exhibits anti-inflammatory and antioxidant effects, which may contribute to its neuroprotective benefits. It has also been explored for its ability to cross the blood-brain barrier effectively, making it a promising candidate for central nervous system-targeted therapies. Research is ongoing to determine its full therapeutic potential and safety profile in humans.